Target intelligence / Profile preview

Eukaryotic translation initiation factor 2 alpha phosphatase

Molecular classification
Enzyme, Protein phosphatase, Regulatory protein complex
01

Overview

Eukaryotic translation initiation factor 2 alpha phosphatase is a cellular enzyme complex that specifically removes phosphate groups from the α subunit of eukaryotic translation initiation factor 2 (eIF2α) after it has been phosphorylated in response to stress. This dephosphorylation step is a critical regulatory event for resuming general protein synthesis following stress recovery. The phosphatase complex consists of protein phosphatase 1 (PP1) as the catalytic core and specific regulatory subunits (primarily GADD34 or CReP in mammals) that confer substrate specificity toward eIF2α. It plays an essential role in controlling the integrated stress response (ISR) by regulating the switch between attenuation and reactivation of global mRNA translation and is implicated in diseases related to stress adaptation, including cancer, neurodegeneration, and infections. Pharmacological inhibitors targeting eIF2α phosphatase are under investigation as potential therapeutics in diseases with dysregulated ISR signaling[2][1].

Other names
eIF2α phosphataseeIF2α-specific phosphatasePPP1R15A/PPP1R15B complexes (when referring to regulatory subunits)GADD34-containing protein phosphatase 1 complexCReP-containing protein phosphatase 1 complex
02

Mechanism of action

Inhibition of eIF2α phosphatase increases eIF2α phosphorylation and sustains stress responses, reducing protein synthesis Release of eIF2α phosphatase inhibition restores normal protein synthesis rates after cellular stress

03

Biological functions

Regulation of protein synthesisIntegrated stress response (ISR) modulationCellular stress adaptationRecovery of translation following stress
04

Disease associations

CancerNeurodegenerative diseaseInfectionMetabolic disease
05

Safety considerations

Chronic modulation of eIF2α phosphorylation can impair cell viability or adaptationExcessive inhibition may cause prolonged translational repression, affecting normal cell function
06

Interacting drugs

Salubrinal (inhibitor of eIF2α dephosphorylation)

1 more in the full profile.

07

Biomarkers

Levels of phosphorylated eIF2α (eIF2α~P)Expression of ISR response genes (ATF4, CHOP)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2 alpha phosphatase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2 alpha phosphatase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call